Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Very high prevalence of infection with the human T cell leukaemia virus type 1c in remote Australian Aboriginal communities: Results of a large cross-sectional community survey
Lloyd Einsiedel, Hai Pham, Mohammad Radwanur Talukder, et al.
PLoS neglected tropical diseases (2021) Vol. 15, Iss. 12, pp. e0009915-e0009915
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

Designing and evaluation of a novel electrochemical biosensor based on carbon quantum dots and gold core-shell to detect and measure Human T-lymphotropic Virus-1 (HTLV-1) in clinical samples
Farkhonde Zibadi, Majid Rezayi, Reza Kazemi Oskuee, et al.
Microchemical Journal (2024) Vol. 201, pp. 110563-110563
Closed Access | Times Cited: 6
Trends of changes in human T-cell leukemia virus type 1 epidemiology in Japan and globally
Noriaki Yoshida, Ayumi Hida, Ritsu Sakata
Leukemia Research (2025) Vol. 150, pp. 107654-107654
Closed Access
Prevalence of HTLV-1/2 infection in pregnant women in Central and South America and the Caribbean: a systematic review and meta-analysis
Juan-Pablo Sánchez-Núñez, E. De Miguel, Vincent Soriano, et al.
International Journal of Infectious Diseases (2024) Vol. 143, pp. 107018-107018
Open Access | Times Cited: 3
High Human T-Cell Leukemia Virus Type 1c Proviral Loads Are Associated With Diabetes and Chronic Kidney Disease: Results of a Cross-Sectional Community Survey in Central Australia
Mohammad Radwanur Talukder, Richard Woodman, Hai Pham, et al.
Clinical Infectious Diseases (2022) Vol. 76, Iss. 3, pp. e820-e826
Closed Access | Times Cited: 14
A role for an HTLV-1 vaccine?
Lee Ratner
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 13
Human T-lymphotropic virus type 1 and antiretroviral therapy: practical considerations for pre-exposure and post-exposure prophylaxis, transmission prevention, and mitigation of severe disease
Jake S. O’Donnell, Noushin Jaberolansar, Keith J. Chappell
The Lancet Microbe (2024) Vol. 5, Iss. 4, pp. e400-e408
Open Access | Times Cited: 2
HTLV-1 Transmission and HIV Pre-exposure Prophylaxis: A Scoping Review
Daniel Bradshaw, Graham P. Taylor
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 11
The slowdown of new infections by human retroviruses has reached a plateau in Spain
Carmen de Mendoza, P. Carrizo, Silvia Sauleda, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 5
Closed Access | Times Cited: 6
Human T Cell Lymphotropic Virus Type 1 Global Prevalence Associated with the Human Development Index: Systematic Review with Meta-Analysis
G. Sampaio, Jéssica Ramos Ribeiro, Celso Nascimento de Almeida, et al.
AIDS Research and Human Retroviruses (2022) Vol. 39, Iss. 4, pp. 145-165
Closed Access | Times Cited: 10
The Association between Diabetes and Human T-Cell Leukaemia Virus Type-1 (HTLV-1) with Strongyloides stercoralis: Results of a Community-Based, Cross-Sectional Survey in Central Australia
Mohammad Radwanur Talukder, Hai Pham, Richard Woodman, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 4, pp. 2084-2084
Open Access | Times Cited: 8
Prophylactic vaccination inducing anti-Env antibodies can result in protection against HTLV-1 challenge in macaques
Midori Nakamura‐Hoshi, Hiroshi Ishii, Takushi Nomura, et al.
Molecular Therapy (2024) Vol. 32, Iss. 7, pp. 2328-2339
Open Access | Times Cited: 1
A Qualitative Study Exploring Perceptions to the Human T Cell Leukaemia Virus Type 1 in Central Australia: Barriers to Preventing Transmission in a Remote Aboriginal Population
Fiona Fowler, Lloyd Einsiedel
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 6
Pantoea abscess mimicking sarcoma in a HTLV‐1‐infected Indigenous Australian man: Case report and literature review
Maja Susanto, Jacki Dunning, Rusheng Chew
Clinical Case Reports (2023) Vol. 11, Iss. 5
Open Access | Times Cited: 2
HTLV-1 Proliferation after CD8 + Cell Depletion by Monoclonal Anti-CD8 Antibody Administration in Latently HTLV-1-Infected Cynomolgus Macaques
Midori Nakamura‐Hoshi, Takushi Nomura, Masako Nishizawa, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 4
Open Access | Times Cited: 2
A protective role of HTLV-1 gp46-specific neutralizing and antibody-dependent cellular cytotoxicity-inducing antibodies in progression to adult T-cell leukemia (ATL)
Yuetsu Tanaka, Reiko Tanaka, Naoki Imaizumi, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 4
Human T-cell leukaemia virus type 1 and Adult T-cell leukaemia/lymphoma in Queensland, Australia: a retrospective cross-sectional study
Fabiola Martin, Charles F. Gilks, Robert Gibb, et al.
Sexually Transmitted Infections (2022) Vol. 99, Iss. 1, pp. 50-52
Open Access | Times Cited: 3
A promising advance in blocking HTLV-1 transmission: Addressing a global public health problem
Antônio Carlos Rosário Vallinoto
Molecular Therapy (2024) Vol. 32, Iss. 7, pp. 2050-2051
Closed Access
The Human T-cell Leukemia Virus capsid protein is a potential drug target
Ruijie Yu, Prabhjeet Phalora, Nan Li, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
The Global Prevalence of HTLV-1 and HTLV-2 Infections among Immigrants and Refugees—A Systematic Review and Meta-Analysis
Thaís Augusto Marinho, Michele Tiemi Okita, Rafael Alves Guimarães, et al.
Viruses (2024) Vol. 16, Iss. 10, pp. 1526-1526
Open Access
Novel insights into human T‐lymphotropic virus type‐1 (HTLV‐1) pathogenesis‐host interactions in the manifestation of HTLV‐1‐associated myelopathy/tropical spastic paraparesis
Sanaz Ahmadi Ghezeldasht, Arman Mosavat, Seyed Abdolrahim Rezaee
Reviews in Medical Virology (2024) Vol. 34, Iss. 4
Closed Access
Demographic, clinical and molecular epidemiology of extended-spectrum beta-lactamase-producing Escherichia coli bloodstream infections in Central Australia
Freya Langham, Danny Tsai, Brian M. Forde, et al.
Pathology (2024) Vol. 56, Iss. 7, pp. 1012-1020
Closed Access
“We Need to Translate Research Into Meaningful HTLV Health Policies and Programs”: Webinar HTLV World Day 2021
Carolina Rosadas, Tatiane Assone, Leandro Soares Sereno, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 2
Prognostic analysis of smoldering ATLL with skin eruptions based on genomic aberrations
Kosuke MOCHIDA, Shingo Nakahata, Yutaka Suzuki, et al.
Journal of Dermatological Science (2023) Vol. 109, Iss. 2, pp. 80-88
Closed Access
Rétrovirus humains T-lymphotropes
Karim Abdelmoumen, Chloé Journo
EMC-Maladies infectieuses/Encyclopédie médico-chirurgicale. Maladies infectieuses (2023) Vol. 40, Iss. 4, pp. 1-14
Closed Access
Pantoea abscess mimicking sarcoma in a HTLV-1-infected Indigenous Australian man: case report and literature review
Maja Susanto, Jacki Dunning, Rusheng Chew
Authorea (Authorea) (2022)
Open Access
Page 1 - Next Page

Scroll to top